Histologically Proven Recurrent Synovitis after Nivolumab Treatment.

Yuki Nakayama,Naoki Sawa,Tatsuya Suwabe,Masayuki Yamanouchi,Daisuke Ikuma,Hiroki Mizuno,Eiko Hasegawa,Akinari Sekine,Yuki Oba,Kazuya Ishiwata,Atsushi Wake,Masaki Hatano,Izuru Kitajima,Kei Kono,Keiichi Kinowaki,Yutaka Takazawa,Tamiko Takemura,Yoshifumi Ubara

Internal Medicine（2024）

引用 0|浏览6

暂无评分

关键词

nivolumab,synovitis,immune checkpoint inhibitor,rheumatoid arthritis,immune-related adverse events

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要